Sector News

Stryker names Timothy Scannell president and COO effective Aug. 1

July 11, 2018
Life sciences

Medical-tech company Stryker Corp. said Tuesday it has named Timothy Scannell president and chief operating officer, effective Aug. 1.

The company is making the change as David Floyd, group president, orthopaedics, is retiring on June 30, 2019. Scannell started his career with Stryker’s endoscopy business in 1990, serving in sales and marketing roles.

For almost a decade, he has been group president, recently overseeing medsurg and neurotechnology. Stryker shares were not active premarket, but have gained 12% in 2018, while the S&P 500 has gained 4%.

By Ciara Linnane

Source: MarketWatch

comments closed

Related News

April 14, 2024

Bayer taps new North America marketing chief for consumer health division

Life sciences

Avivi joins Bayer fresh off a yearlong stint as chief marketing officer of Advance Auto Parts, which followed about three years spent as marketing chief of another auto parts company, Tenneco. Rounding out her nearly 30-year career in marketing are leadership roles at consumer goods giants Kimberly-Clark and Procter & Gamble.

April 14, 2024

Air Liquide acquires healthcare businesses in Belgium and the Netherlands

Life sciences

Air Liquide S.A. (Paris) is continuing its development with the acquisition of Homecare activities in Belgium and the Netherlands. The two entities acquired in Belgium and the Netherlands support 10,000 patients living with respiratory insufficiency, sleep apnea syndrome or requiring infusion or nutrition treatments.

April 14, 2024

Vertex to acquire Alpine Immune Sciences for $4.9 billion

Life sciences

US-based Vertex Pharmaceuticals has agreed to pay approximately $4.9 billion in cash to acquire Alpine Immune Sciences, a compatriot biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.

How can we help you?

We're easy to reach